MuSiC: Identifying Mutational Significance in Cancer Genomes

Overview

Journal Genome Res

Specialty Genetics

Date 2012 Jul 5

PMID 22759861

Citations 373

Authors

Nathan D Dees

Qunyuan Zhang

Cyriac Kandoth

Michael C Wendl

William Schierding

Daniel C Koboldt

Thomas B Mooney

Matthew B Callaway

David Dooling

Elaine R Mardis

Richard K Wilson

Li Ding

Affiliations

Soon will be listed here.

Abstract

Massively parallel sequencing technology and the associated rapidly decreasing sequencing costs have enabled systemic analyses of somatic mutations in large cohorts of cancer cases. Here we introduce a comprehensive mutational analysis pipeline that uses standardized sequence-based inputs along with multiple types of clinical data to establish correlations among mutation sites, affected genes and pathways, and to ultimately separate the commonly abundant passenger mutations from the truly significant events. In other words, we aim to determine the Mutational Significance in Cancer (MuSiC) for these large data sets. The integration of analytical operations in the MuSiC framework is widely applicable to a broad set of tumor types and offers the benefits of automation as well as standardization. Herein, we describe the computational structure and statistical underpinnings of the MuSiC pipeline and demonstrate its performance using 316 ovarian cancer samples from the TCGA ovarian cancer project. MuSiC correctly confirms many expected results, and identifies several potentially novel avenues for discovery.

Citing Articles

MONet: cancer driver gene identification algorithm based on integrated analysis of multi-omics data and network models.

Ren Y, Zhang T, Liu J, Ma F, Chen J, Li P Exp Biol Med (Maywood). 2025; 250:10399.

PMID: 39968416 PMC: 11834253. DOI: 10.3389/ebm.2025.10399.

Identifying somatic driver mutations in cancer with a language model of the human genome.

Zeng G, Zhao C, Li G, Huang Z, Zhuang J, Liang X Comput Struct Biotechnol J. 2025; 27:531-540.

PMID: 39968174 PMC: 11833646. DOI: 10.1016/j.csbj.2025.01.011.

Case report: Detection and treatment of a rare submucosal gland duct adenoma of the esophagus.

Zhou Y, He D, Huang Z, Chen Z, Zhou Z, Duan H Front Oncol. 2025; 14:1482068.

PMID: 39886666 PMC: 11779616. DOI: 10.3389/fonc.2024.1482068.

DriverDetector: An R package providing multiple statistical methods for cancer driver genes detection and tools for downstream analysis.

Wang Z, Gu H, Qin P, Wang J Heliyon. 2025; 10(14):e33582.

PMID: 39816349 PMC: 11733820. DOI: 10.1016/j.heliyon.2024.e33582.

Molecular characterization of EBV-associated primary pulmonary lymphoepithelial carcinoma by multiomics analysis.

Yang M, Zheng G, Chen F, Tang H, Liu Y, Gao X BMC Cancer. 2025; 25(1):85.

PMID: 39815193 PMC: 11734413. DOI: 10.1186/s12885-024-13410-3.

References

Forbes S, Bhamra G, Bamford S, Dawson E, Kok C, Clements J . The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet. 2008; Chapter 10:Unit 10.11. PMC: 2705836. DOI: 10.1002/0471142905.hg1011s57. View

Tarca A, Draghici S, Khatri P, Hassan S, Mittal P, Kim J . A novel signaling pathway impact analysis. Bioinformatics. 2008; 25(1):75-82. PMC: 2732297. DOI: 10.1093/bioinformatics/btn577. View

Carter H, Samayoa J, Hruban R, Karchin R . Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM). Cancer Biol Ther. 2010; 10(6):582-7. PMC: 3040948. DOI: 10.4161/cbt.10.6.12537. View

Joshi-Tope G, Gillespie M, Vastrik I, DEustachio P, Schmidt E, de Bono B . Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 2004; 33(Database issue):D428-32. PMC: 540026. DOI: 10.1093/nar/gki072. View

Finn R, Mistry J, Tate J, Coggill P, Heger A, Pollington J . The Pfam protein families database. Nucleic Acids Res. 2009; 38(Database issue):D211-22. PMC: 2808889. DOI: 10.1093/nar/gkp985. View

Vaske C, Benz S, Sanborn J, Earl D, Szeto C, Zhu J . Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics. 2010; 26(12):i237-45. PMC: 2881367. DOI: 10.1093/bioinformatics/btq182. View

Lin J, Gan C, Zhang X, Jones S, Sjoblom T, Wood L . A multidimensional analysis of genes mutated in breast and colorectal cancers. Genome Res. 2007; 17(9):1304-18. PMC: 1950899. DOI: 10.1101/gr.6431107. View

Ahmed A, Etemadmoghadam D, Temple J, Lynch A, Riad M, Sharma R . Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol. 2010; 221(1):49-56. PMC: 3262968. DOI: 10.1002/path.2696. View

Ding L, Getz G, Wheeler D, Mardis E, McLellan M, Cibulskis K . Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008; 455(7216):1069-75. PMC: 2694412. DOI: 10.1038/nature07423. View

10.

Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38(16):e164. PMC: 2938201. DOI: 10.1093/nar/gkq603. View

11.

Kaminker J, Zhang Y, Watanabe C, Zhang Z . CanPredict: a computational tool for predicting cancer-associated missense mutations. Nucleic Acids Res. 2007; 35(Web Server issue):W595-8. PMC: 1933186. DOI: 10.1093/nar/gkm405. View

12.

Sigal A, Rotter V . Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res. 2001; 60(24):6788-93. View

13.

Schultz J, Copley R, Doerks T, Ponting C, Bork P . SMART: a web-based tool for the study of genetically mobile domains. Nucleic Acids Res. 1999; 28(1):231-4. PMC: 102444. DOI: 10.1093/nar/28.1.231. View

14.

Reva B, Antipin Y, Sander C . Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 2011; 39(17):e118. PMC: 3177186. DOI: 10.1093/nar/gkr407. View

15.

Adzhubei I, Schmidt S, Peshkin L, Ramensky V, Gerasimova A, Bork P . A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7(4):248-9. PMC: 2855889. DOI: 10.1038/nmeth0410-248. View

16.

Sigrist C, Cerutti L, de Castro E, Langendijk-Genevaux P, Bulliard V, Bairoch A . PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Res. 2009; 38(Database issue):D161-6. PMC: 2808866. DOI: 10.1093/nar/gkp885. View

17.

Getz G, Hofling H, Mesirov J, Golub T, Meyerson M, Tibshirani R . Comment on "The consensus coding sequences of human breast and colorectal cancers". Science. 2007; 317(5844):1500. DOI: 10.1126/science.1138764. View

18.

Moumne L, Batista F, Benayoun B, Nallathambi J, Fellous M, Sundaresan P . The mutations and potential targets of the forkhead transcription factor FOXL2. Mol Cell Endocrinol. 2007; 282(1-2):2-11. DOI: 10.1016/j.mce.2007.11.006. View

19.

Wendl M, Wallis J, Lin L, Kandoth C, Mardis E, Wilson R . PathScan: a tool for discerning mutational significance in groups of putative cancer genes. Bioinformatics. 2011; 27(12):1595-602. PMC: 3106187. DOI: 10.1093/bioinformatics/btr193. View

20.

. Integrated genomic analyses of ovarian carcinoma. Nature. 2011; 474(7353):609-15. PMC: 3163504. DOI: 10.1038/nature10166. View